India has crossed a peak of its COVID-19 epidemic but with the end nowhere in sight, any news of a vaccine is bound to generate excitement.
Three major companies recently announced preliminary results from the phase 3 clinical trials for their vaccine candidates: AstraZeneca, Pfizer and Moderna.
Any celebrations over a potential vaccine must be tempered with caution as the information available so far paints a very limited picture.